NewtekOne, Inc. (NEWT) · Nov 18, 2026 · New debt
$5M additional notes — $29M total 2029 notes after the $24M exchange
NewtekOne’s new debt filing adds $5 million of 8.125% notes due 2029, extending funding as a $26 million 2027 maturity remains.
NewtekOne is expanding its small-business banking and lending platform, with loans above $2.7 billion and full-year 2026 EPS guidance of $1.70-$1.80 maintained after the third quarter. The filing adds a modest funding cushion. NewtekOne sold another $5.0 million of 8.125% senior notes due February 1, 2029, taking that series to $29.0 million including the $24.0 million issued in October. 〔0〕 This is maturity management, not a cheaper refinancing. The new notes carry the same 8.125% coupon as the October exchange, so the company gains additional capital and pushes part of its funding farther out, but does not reduce interest expense. The broader balance-sheet task is only partly solved: the prior filing said $26.0 million of older notes was still expected to come due on February 1, 2027. The news is helpful but limited in scale. Against a rapidly growing lending business, $5 million is a small capital action rather than a change to NewtekOne’s operating strategy or financial outlook. It slightly improves near-term flexibility, while leaving the February 2027 repayment obligation as the next concrete funding checkpoint. Bottom line: This is a modestly constructive liquidity step, not a transformational financing. It extends part of NewtekOne’s debt profile but leaves the company paying the same high coupon and still facing a near-term maturity to address.
Repayment of remaining $26M notes on February 1, 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!